Skip to main content

Advertisement

SpringerLink
Log in

Management of chronic constipation in patients with diabetes mellitus

  • Review Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Aim

The aim of this review is to provide an overview of the clinical assessment and evidence-based treatment options for managing diabetes-associated chronic constipation.

Methods

A literature search of published medical reports in English language was performed using the OVID Portal, from PUBMED and the Cochrane Database of Systematic Reviews, from inception to October 2015. A total of 145 abstracts were identified; duplicate publications were removed and 95 relevant full-text articles were retrieved for potential inclusion.

Results

Chronic constipation is one of the most common gastrointestinal symptoms in patients with diabetes, and occurs more frequently than in healthy individuals. Treatment goals include improving symptoms and restoring bowel function by accelerating colonic transit and facilitating defecation. Based on guidelines and data from published literature, food and dietary change with exercise and lifestyle change should be the first step in management. For patients recalcitrant to these changes, laxatives should be the next step of treatment. Treatment should begin with bulking agents such as psyllium, bran or methylcellulose followed by osmotic laxatives if response is poor. Lactulose, polyethylene glycol and lactitol are the most frequently prescribed osmotic agents. Lactulose has a prebiotic effect and a carry-over effect (continued laxative effect for at least 6 to 7 days, post cessation of treatment). Stimulants such as bisacodyl, sodium picosulphate and senna are indicated if osmotic laxatives are not effective. Newer agents such as chloride-channel activators and 5-HT4 agonist can be considered for severe or resistant cases.

Conclusion

The primary aim of intervention in diabetic patients with chronic constipation is to better manage the diabetes along with management of constipation. The physician should explain the rationale for prescribing laxatives and educate patients about the potential drawbacks of long-term use of laxatives. They should contact their physician if short-term use of prescribed laxative fails to provide relief.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. 5th Edition of the Diabetes Atlas released on World Diabetes Day. Brussels, Belgium: International Diabetes Federation, 2011. Available via DIALOG http://www.ncbi.nlm.nih.gov/pubmed/26371734. Accessed 6 April 2013.

  2. Hu FB. Globalization of diabetes—the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249–57.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Estimates by ‘Public health foundation of India’. Available via. DIALOG http://ccebdm.org/news.php. Accessed 16 May 2016.

  4. Forgacs I, Patel V. Diabetes and the gastrointestinal tract. Medicine. 2011;39:288–92.

    Article  Google Scholar 

  5. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.

    Article  PubMed  Google Scholar 

  6. Phillips LK, Rayner CK, Jones KL, Horowitz M. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep. 2006;6:417–23.

    Article  CAS  PubMed  Google Scholar 

  7. Ueno N, Inui A, Satoh Y. The effect of mosapride citrate on constipation in patients with diabetes. Diabetes Res Clin Pract. 2010;87:27–32.

    Article  CAS  PubMed  Google Scholar 

  8. Cheng C, Chan AO, Hui WM, Lam SK. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study. Aliment Pharmacol Ther. 2003;18:319–26.

    Article  CAS  PubMed  Google Scholar 

  9. Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808–16.

  10. Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32:637–41.

    CAS  PubMed  Google Scholar 

  11. Schvarcz E, Palmer M, Ingberg CM, Aman J, Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med. 1996;13:478–81.

    Article  CAS  PubMed  Google Scholar 

  12. Janatuinen E, Pikkarainen P, Laakso M, Pyorala K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol. 1993;28:427–32.

    Article  CAS  PubMed  Google Scholar 

  13. Ray G. Evaluation of the symptoms of constipation in Indian patients. J Clin Diagn Res. 2016;10:OC01–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Oh JH, Choi MG, Kang MI, et al. The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus. Korean J Intern Med. 2009;24:309–17.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Maxton DG, Whorwell PJ. Functional bowel symptoms in diabetes—the role of autonomic neuropathy. Postgrad Med J. 1991;67:991–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Belsey J, Greenfield S, Candy D, Geraint M. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther. 2010;31:938–49.

    CAS  PubMed  Google Scholar 

  17. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastoenterol. 1997;32:920–4.

    Article  CAS  Google Scholar 

  18. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.

    Article  PubMed  Google Scholar 

  19. Tack J, Muller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol. 2009;7:502–8.

    Article  CAS  PubMed  Google Scholar 

  20. Tack J, Muller-Lissner S, Stanghellini V, et al. Diagnosis and treatment of chronic constipation—a European perspective. Neurogastroenterol Motil. 2011;23:697–710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. doi:10.1053/j.gastro.2016.02.031.

  22. Vrees DM, Weiss EG. The evaluation of constipation. Clin Colon Rectal Surg. 2005;18:65–75.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bekele G, Kabadi UM. Gastrointestinal manifestations of diabetes mellitus. Int J Diab Dev Countries. 1996;16:54–8.

    Google Scholar 

  24. Battle WM, Snape WJ, Alavi A, Cohen S, Braunstein S. Colonic dysfunction in diabetes mellitus. Gastroenterology. 1980;79:1217–21.

    CAS  PubMed  Google Scholar 

  25. Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med. 1985;102:197–9.

    Article  CAS  PubMed  Google Scholar 

  26. Takahashi T, Matsuda K, Kono T, Pappas TN. Inhibitory effects of hyperglycemia on neural activity of the vagus in rats. Intensive Care Med. 2003;29:309–11.

    Article  PubMed  Google Scholar 

  27. Horvath VJ, Vittal H, Lorincz A, et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology. 2006;130:759–70.

    Article  CAS  PubMed  Google Scholar 

  28. Sanders KM. Interstitial cells of cajal at the clinical and scientific interface. J Physiol. 2006;576 Pt 3:683–7.

  29. Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001;96:3130–7.

    Article  CAS  PubMed  Google Scholar 

  30. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005;100 Suppl 1:S1–4.

  31. Spiller RC, Thompson WG. Bowel disorders. Am J Gastroenterol. 2010;105:775–85.

    Article  PubMed  Google Scholar 

  32. Rao SS, Welcher KD, Leistikow JS. Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol. 1998;93:1042–50.

    Article  CAS  PubMed  Google Scholar 

  33. Rao SS. Dyssynergic defecation. Gastroenterol Clin N Am. 2001;30:97–114.

    Article  CAS  Google Scholar 

  34. Bharucha AE, Wald AM. Anorectal disorders. Am J Gastroenterol. 2010;105:786–94.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Muller-Lissner S. The pathophysiology, diagnosis and treatment of constipation. Dtsch Arztebl Int. 2009;106:424–31.

    PubMed  PubMed Central  Google Scholar 

  36. Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004;17:59–67.

    Article  PubMed  Google Scholar 

  37. Bleser S, Brunton S, Carmichael B, Olden K, Rasch R, Steege J. Management of chronic constipation: recommendations from a consensus panel. J Fam Pract. 2005;54:691–8.

    PubMed  Google Scholar 

  38. Jamshed N, Lee ZE, Olden KW. Diagnostic approach to chronic constipation in adults. Am Fam Physician. 2011;84:299–306.

    PubMed  Google Scholar 

  39. Gwee KA, Ghoshal UC, Gonlachanvit S, et al. Primary care management of chronic constipation in Asia: the ANMA chronic constipation tool. J Neurogastroenterol Motil. 2013;19:149–60.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kay RM. Dietary fiber. J Lipid Res 1982;23:221–42.

  41. Stephen AM, Cummings JH. Mechanism of action of dietary fiber in the human colon. Nature. 1980;284:283–4.

  42. American Diabetes Association. Standards of medical care in diabetes—2016. Diabetes Care. 2016;39:S1–S106.

    Article  Google Scholar 

  43. Chen HL, Haack VS, Janecky CW, Vollendorf NW, Marlett JA. Mechanisms by which wheat bran and oat bran increase stool weight in humans. Am J Clin Nutr. 1998;68:711–9.

    CAS  PubMed  Google Scholar 

  44. Tandon R, Babu S, Chhabra M, et al. Constipation, New Delhi/Gurgaon, Reed Elsevier India Pvt. Ltd, 2013;1–60.

  45. Badiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci. 1995;40:349–56.

    Article  CAS  PubMed  Google Scholar 

  46. Graham DY, Moser SE, Estes MK. The effect of bran on bowel function in constipation. Am J Gastroenterol. 1982;77:599–603.

    CAS  PubMed  Google Scholar 

  47. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for reappraisal. Lancet. 1994;344:39–40.

    Article  CAS  PubMed  Google Scholar 

  48. Voderholzer WA, Schatke W, Muhldorfer BE, Klauser AG, Birkner B, Muller-Lissner SA. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol. 1997;92:95–8.

    CAS  PubMed  Google Scholar 

  49. Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes. Diabetes Care. 2010;33:e147–67.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA. 1998;280:1490–6.

    Article  CAS  PubMed  Google Scholar 

  51. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care. 1997;20:537–44.

    Article  CAS  PubMed  Google Scholar 

  52. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2008;371:1783–9.

    Article  PubMed  Google Scholar 

  53. Knowler WC, Fowler SE, Hamman RF, et al. For diabetes prevention program research group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374:1677–86.

    Article  PubMed  Google Scholar 

  54. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet. 2006;368:1673–9.

    Article  PubMed  Google Scholar 

  55. Tuomilehto J, Lindstrom J, Eriksson JG, et al. For Finnish diabetes prevention study group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    Article  CAS  PubMed  Google Scholar 

  56. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. For Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–97.

    Article  CAS  PubMed  Google Scholar 

  57. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242–9.

    Article  CAS  PubMed  Google Scholar 

  58. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010; 5: e9085.

  59. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut micrflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374–83.

    Article  CAS  PubMed  Google Scholar 

  60. Tuohy KM, Rouzaud GC, Bruck WM, Gibson GR. Modulation of the human gut microflora towards improved health using prebiotics—assessment of efficacy. Curr Pharm Des. 2005;11:75–90.

    Article  CAS  PubMed  Google Scholar 

  61. Embarrassing bodies. Constipation. Treatment. NHS choices. Available via DIALOG.http://www.channel4embarrassingillnesses.com/men-in-white-coats/constipation/treatment. Accessed 17 May 2016.

  62. Tramonte SM, Brand MB, Mulrow CD, Amato MG, O’Keefe ME, Ramirez G. The treatment of chronic constipation in adults. A systematic review. J Gen Intern Med. 1997;12:15–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Odes HS, Madar Z. A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation. Digestion. 1991;49:65–71.

    Article  CAS  PubMed  Google Scholar 

  64. Coggrave M, Norton C, Cody JD. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev. 2014; CD002115.

  65. Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011;33:895–901.

    Article  CAS  PubMed  Google Scholar 

  66. McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther. 1998;12:491–7.

    Article  CAS  PubMed  Google Scholar 

  67. Cheskin LJ, Kamal N, Crowell MD, Schuster MM, Whitehead WE. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geriatr Soc. 1995;43:666–9.

    Article  CAS  PubMed  Google Scholar 

  68. Ashraf W, Park F, Lof J, Quigley EM. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther. 1995;9:639–47.

    Article  CAS  PubMed  Google Scholar 

  69. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr. 2002;56:830–42.

    Article  CAS  PubMed  Google Scholar 

  70. Emmanuel A. Current management of strategies and therapeutic targets in chronic constipation. Therap Adv Gastroenterol. 2011;4:37–48.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010; CD007570.

  72. Genovese S, Riccardi G, Rivellese AA. Lactulose improves blood glucose response to an oral glucose test in non-insulin dependent diabetic patients. Diabetes Nutr Metab. 1992;5:295–7.

  73. Cummings JH, Englyst HN. Fermentation in the human large intestine and the available substrates. Am J Clin Nutr. 1987;45:1243–55.

    CAS  PubMed  Google Scholar 

  74. Bouhnik Y, Neut C, Raskine L, et al. Prospective, randomized parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Aliment Pharmacol Ther. 2004;19:889–99.

    Article  CAS  PubMed  Google Scholar 

  75. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol Suppl. 1997;222:41–4.

    Article  CAS  PubMed  Google Scholar 

  76. Sanders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc. 1978;26:236–9.

    Article  CAS  PubMed  Google Scholar 

  77. Wesselius-De Casparis A, Braadbaart S, Bergh-Bohlken GE, Mimica M. Treatment of chronic constipation with lactulose syrup: results of a double-blind study. Gut. 1968;9:84–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Rouse M, Chapman N, Mahapatra M, Grillage M, Atkinson SN, Prescott P. An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults. Br J Clin Pract. 1991;45:28–30.

    CAS  PubMed  Google Scholar 

  79. Connolly P, Hughes IW, Ryan G. Comparison of “Duphalac” “and irritant” laxatives during and after treatment of chronic constipation: a preliminary study. Curr Med Res Opin. 1974;2:620–5.

    Article  PubMed  Google Scholar 

  80. Culbert P, Gillett H, Ferguson A. Highly effective new oral therapy for faecal impaction. Br J Gen Pract. 1998;48:1599–600.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Chen CC, Su MY, Tung SY, Chang FY, Wong JM, Geraint M. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults. Curr Med Res Opin. 2005;21:1595–602.

    Article  CAS  PubMed  Google Scholar 

  82. Dipalma JA, Cleveland MV, McGowan J, Herrera JL. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol. 2007;102:1436–41.

    Article  CAS  PubMed  Google Scholar 

  83. Paille FCN, Alleaume B, Vicari F. An open six-month study of the safety of Transipeg for treating constipation in community medicine. J Clin Res. 1992;2:65–76.

    Google Scholar 

  84. Chaussade S, Minić M. Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation. Aliment Pharmacol Ther. 2003;17:165–72.

    Article  CAS  PubMed  Google Scholar 

  85. Dupont C, Leluyer B, Maamri N, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr. 2005;41:625–33.

    Article  CAS  PubMed  Google Scholar 

  86. Di Palma JA, Cleveland MV, McGowan J, Herrera JL. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation. Am J Gastroenterol. 2007;102:1964–71.

    Article  CAS  PubMed  Google Scholar 

  87. Migeon-Duballet I, Chabin M, Gautier A, et al. Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population. Curr Med Res Opin. 2006;22:1227–35.

    Article  CAS  PubMed  Google Scholar 

  88. Corazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut. 2000;46:522–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Loening-Baucke V, Pashankar D. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. Pediatrics. 2006;118:528–35.

    Article  PubMed  Google Scholar 

  90. Petticrew M, Rodgers M, Booth A. Effectiveness of laxatives in adults. Qual Health Care. 2001;10:268–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Freedman MD, Schwartz HJ, Roby R, Fleisher S. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial. J Clin Pharmacol. 1997;37:904–7.

    Article  CAS  PubMed  Google Scholar 

  92. Izzo AA, Gaginella TS, Mascolo N, Capasso F. Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol. 1994;113:228–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Izzo AA, Gaginella TS, Capasso F. The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnes Res. 1996;9:133–8.

    CAS  PubMed  Google Scholar 

  94. Kinnunen O, Salokannel J. Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res. 1987;19:321–3.

    CAS  PubMed  Google Scholar 

  95. Constipation treatment. NHS choices. Available via DIALOG. http://www.nhs.uk/Conditions/Constipation/Pages/Treatment.aspx. Accessed 17 May 2016.

  96. Emmanuel A, Cools M, Vandeplassche L, et al. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis. Am J Gastroenterol. 2014;109:887–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Emmanuel AV, Roy AJ, Nicholls TJ, Kamm M. Prucalopride, a systemic enterokinetic, for the treatment of constipation. Aliment Pharmacol Ther. 2002;16:1347–56.

    Article  CAS  PubMed  Google Scholar 

  98. Quigley EM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation: a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29:315–28.

    Article  CAS  PubMed  Google Scholar 

  99. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008;358:2344–54.

    Article  CAS  PubMed  Google Scholar 

  100. Sweetser S, Busciglio IA, Camilleri M, et al. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2009;296:G295–301.

    Article  CAS  PubMed  Google Scholar 

  101. Johanson JF, Morton D, Geenen J, Ueno R. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol. 2008;103:170–7.

    Article  CAS  PubMed  Google Scholar 

  102. Johanson JF, Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, doseranging study to evaluate efficacy and safety. Aliment Pharmacol Ther. 2007;25:1351–61.

    Article  CAS  PubMed  Google Scholar 

  103. Barish CF, Drossman D, Johanson JF, Ueno R. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci. 2010;55:1090–7.

    Article  CAS  PubMed  Google Scholar 

  104. Sucampo receives marketing authorization for Amitiza in Switzerland for treatment of chronic idiopathic constipation, 2009. Sucampo Pharma Europe Ltd. Available via DIALOG. http://www.sucampo.com. Accessed 7 June 2010.

  105. Lembo AJ, Kurtz CB, Macdougall JE, et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010;138:886–95.

    Article  CAS  PubMed  Google Scholar 

  106. Carson RT, Tourkodimitris S, Macdougall JE, et al. Effect of linaclotide on quality of life in adults with chronic constipation: results from two randomized, double-blind, placebo-controlled phase 3 trials. Presented at DDW, May 1–5 2010. Abstract [847d].

  107. Johnston JM, Schneier H, Lavins BJ, et al. Results from the randomized withdrawal period of a phase 3 clinical trial of linaclotide in chronic constipation. Presented at DDW, May 1–5 2010. Abstract [T1817].

  108. McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther. 1998;12:491–7.

    Article  CAS  PubMed  Google Scholar 

  109. Cheskin LJ, Kamal N, Crowell MD, Schuster MM, Whitehead WE. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geriatr Soc. 1995;43:666–9.

    Article  CAS  PubMed  Google Scholar 

  110. Ashraf W, Park F, Lof J, Quigley EM. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther. 1995;9:639–47.

    Article  CAS  PubMed  Google Scholar 

  111. Tomas-Ridocci M, Anon R, Minguez M, Zaragoza A, Ballester J, Benages A. The efficacy of Plantago ovata as a regulator of intestinal transit: a doubleblind study compared to placebo. Rev Esp Enferm Dig. 1992;82:17–22.

    CAS  PubMed  Google Scholar 

  112. Sturtzel B, Elmadfa I. Intervention with dietary fiber to treat constipation and reduce laxative use in residents of nursing homes. Ann Nutr Metab. 2008;52:54–6.

    Article  CAS  PubMed  Google Scholar 

  113. Sturtzel B, Mikulits C, Gisinger C, Elmadfa I. Use of fiber instead of laxative treatment in a geriatric hospital to improve the wellbeing of seniors. J Nutr Health Aging. 2009;13:136–9.

    Article  CAS  PubMed  Google Scholar 

  114. Hamilton JW, Wagner J, Burdick BB, Bass P. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci. 1988;33:993–8.

    Article  CAS  PubMed  Google Scholar 

  115. Petticrew M, Watt I, Sheldon T. Systematic review of the effectiveness of laxatives in the elderly. Health Technol Assess. 1997;1:1–52.

    Google Scholar 

  116. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol. 2000;95:446–50.

    Article  CAS  PubMed  Google Scholar 

  117. Cleveland MV, Flavin DP, Ruben RA, Epstein RM, Clark GE. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J. 2001;94:478–81.

    Article  CAS  PubMed  Google Scholar 

  118. Passmore AP, Davies KW, Flanagan PG, Stroker C, Scott MG. A comparison of Agiolax and lactulose in elderly patients with chronic constipation. Pharmacology. 1993;47:249–52.

    Article  PubMed  Google Scholar 

  119. Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fiber combination. BMJ. 1993;307:769–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Marlett JA, Li BU, Patrow CJ, Bass P. Comparative laxation of psyllium with and without senna in an ambulatory constipated population. Am J Gastroenterol. 1987;82:333–7.

    CAS  PubMed  Google Scholar 

  121. Muller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA. Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation. Am J Gastroenterol. 2006;101:2558–69.

    Article  PubMed  Google Scholar 

  122. Towers AL, Burgio KL, Locher JL, Merkel IS, Safaeian M, Wald A. Constipation in the elderly: influence of dietary, psychological, and physiological factors. J Am Geriatr Soc. 1994;42:701–6.

    Article  CAS  PubMed  Google Scholar 

  123. Dukas L, Willett WC, Giovannucci EL. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol. 2003;98:1790–6.

    Article  PubMed  Google Scholar 

  124. Murakami K, Sasaki S, Okubo H, et al. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr. 2007;61:616–22.

    Article  CAS  PubMed  Google Scholar 

  125. Okubo H, Sasaki S, Murakami K, et al. Dietary patterns associated with functional constipation among Japanese women aged 18 to 20 years: a cross-sectional study. J Nutr Sci Vitaminol (Tokyo). 2007;53:232–8.

    Article  CAS  Google Scholar 

  126. Lindeman RD, Romero LJ, Liang HC, Baumgartner RN, Koehler KM, Garry PJ. Do elderly persons need to be encouraged to drink more fluids? J Gerontol A Biol Sci Med Sci. 2000;55:M361–5.

    Article  CAS  PubMed  Google Scholar 

  127. Leung FW. Etiologic factors of chronic constipation: review of the scientific evidence. Dig Dis Sci. 2007;52:313–6.

    Article  PubMed  Google Scholar 

  128. Brown WJ, Mishra G, Lee C, Bauman A. Leisure time physical activity in Australian women: relationship with well being and symptoms. Res Q Exerc Sport. 2000;71:206–16.

    Article  CAS  PubMed  Google Scholar 

  129. De Schryver AM, Keulemans YC, Peters HP, et al. Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation. Scand J Gastroenterol. 2005;40:422–9.

    Article  PubMed  Google Scholar 

  130. Meshkinpour H, Selod S, Movahedi H, Nami N, James N, Wilson A. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci. 1998;43:2379–83.

    Article  CAS  PubMed  Google Scholar 

  131. Robson KM, Kiely DK, Lembo T. Development of constipation in nursing home residents. Dis Colon Rectum. 2000;43:940–3.

  132. Anti M, Pignataro G, Armuzzi A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998;45:727–32.

Download references

Acknowledgements

The assistance for conducting literature search and writing was provided by Shalaka Marfatia of pharmEDGE and her team.

Author information

Authors and Affiliations

  1. VGM Hospital, 2100, Trichy Road, Coimbatore, 641 005, India

    V. G. M. Prasad

  2. P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai, 400 016, India

    Philip Abraham

Authors
  1. V. G. M. Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. G. M. Prasad.

Ethics declarations

Conflicts of interest

VGMP, and PA declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prasad, V.G.M., Abraham, P. Management of chronic constipation in patients with diabetes mellitus. Indian J Gastroenterol 36, 11–22 (2017). https://doi.org/10.1007/s12664-016-0724-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-016-0724-2

Keywords

Search

Navigation